Complaint Counsel's Post Trial Brief - Federal Trade Commission
Complaint Counsel's Post Trial Brief - Federal Trade Commission
Complaint Counsel's Post Trial Brief - Federal Trade Commission
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
246. Duke does not recall any holistic physicians who have consulted with him on the<br />
treatment of cancer. (R18 (Duke, Dep. at 19)).<br />
247. Duke does not recall any homeopaths who have consulted with him on the treatment of<br />
cancer. (R18 (Duke, Dep. at 19)).<br />
248. Duke has never managed or paricipated in any studies to measure the effcacy of an herb<br />
in treating cancer. (R18 (Duke, Dep. at 29); Duke, Tr. 522).<br />
249. Duke does not remember ever being a consultant on a study where the anticancer effects<br />
of an herb were being measured on a group of patients. (R18 (Duke, Dep. at 29-30);<br />
Duke, Tr. 523).<br />
250. Duke does not remember seeing the FTC's <strong>Complaint</strong> against Respondents. (R18 (Duke,<br />
Dep. at 36)).<br />
251. Duke has no knowledge of any of the adverisements that the FTC has challenged as the<br />
predicate for the <strong>Complaint</strong>. (R18 (Duke, Dep. at 36-37); Duke, Tr. 534).<br />
252. Dukewas not sent any of<br />
Respondents' products and has never seen them. (R18 (Duke,<br />
Dep. at 37); Duke, Tr. 524).<br />
253. Duke has not spoken to any persons who have taken DCO products for the treatment of<br />
cancer. (R18 (Duke, Dep. at 38)).<br />
254. Duke has not reviewed the medical records of anyone who clais to have taken DCO<br />
products for the treatment of cancer. (R18 (Duke, Dep. at 39)).<br />
255. Duke had never heard ofDCO until ths case. (R18 (Duke, Dep. at 39)).<br />
256. Duke remembers being quite surrised when he leared that most ofthe list of chemcals<br />
that Respondents were studyig were not biblical. (Duke, Tr. 536.)<br />
257. Duke has never listened to the DCO Radio program. (R18 (Duke, Dep. at 39)).<br />
258. Duke knows of no tests where the patient prays and one group of patients gets a<br />
Biblically referenced herb and the other group of patient prays and gets an allopathc<br />
treatment. (R18 (Duke, Dep. at 41-42)).<br />
259. Duke does not th that ''the FDA perts adverising for cancer uness clincally<br />
proven." (R18 (Duke, Dep. at 46)).<br />
260. Duke's "Multiple Activity Menus" ("MAs") are an attempt to identify herbs that show<br />
promise in fightig disease. (R18 (Duke, Dep. at 91)).<br />
261. The MA and the ratio that it yields does not prove that anyone of these herbs is<br />
effective in fighting or treating cancer. Rather, "(i)t adds a listing of the chemicals in that<br />
herb that have been shown or assumed to help with cancer." (R18 (Duke, Dep. at 92)).<br />
25